New!

Learn more about mir-THYpe RET-hereditary, for germline/hereditary investigation of familial medullary thyroid cancer by the RET proto-oncogene

Facebook Linkedin Instagram

New test!

Learn more about mir-THYpe RET-hereditary

ONKOS - logo header JUN23 (1)
  • About Us
    • Our history
    • Mission, Vision, Values
    • Onkers
    • Awards and Recognitions
    • Science R&D
  • Our Tests
    • mir-THYpe
      • mir-THYpe full
      • mir-THYpe pre-op
      • mir-THYpe target
      • mir-THYpe RET-hereditary
  • Blog
  • Contact
  • International
  • About Us
    • Our history
    • Mission, Vision, Values
    • Onkers
    • Awards and Recognitions
    • Science R&D
  • Our Tests
    • mir-THYpe
      • mir-THYpe full
      • mir-THYpe pre-op
      • mir-THYpe target
      • mir-THYpe RET-hereditary
  • Blog
  • Contact
  • International
English
  • Português
  • Español
Resultado de Exames
ONKOS - logo header JUN23 (1)
  • About Us
    • Our history
    • Mission, Vision, Values
    • Onkers
    • Awards and Recognitions
    • Science R&D
  • Our Tests
    • mir-THYpe
      • mir-THYpe full
      • mir-THYpe pre-op
      • mir-THYpe target
      • mir-THYpe RET-hereditary
  • Blog
  • Contact
  • International
  • English
    • Português
    • English
    • Español
  • About Us
    • Our history
    • Mission, Vision, Values
    • Onkers
    • Awards and Recognitions
    • Science R&D
  • Our Tests
    • mir-THYpe
      • mir-THYpe full
      • mir-THYpe pre-op
      • mir-THYpe target
      • mir-THYpe RET-hereditary
  • Blog
  • Contact
  • International
  • English
    • Português
    • English
    • Español
Resultado de Exames

Who we are

Highlights

What are the treatments for thyroid nodules?

13 de March de 2023
Patient Journey

Everything about the Bethesda System for Thyroid

19 de December de 2022

How can molecular tests help in the management of thyroid nodules?

24 de August de 2022

Social

Be part of the Onkos community!

LinkedIn

Job openings and careers

Instagram

Daily updates for our followers

Facebook

We share interesting news about the medical world

Onkos Molecular Diagnostics

We are the leading laboratory in the development of molecular tests for oncology in Latin America. Our tests are based on gene expression profiling (microRNA) and genetic markers (DNA mutations).

Contact
  • Patient Service: Whatsapp: (16) 99700-4265
  • Physician Support: Whatsapp: (16) 99159-3786
  • Operating hours: Monday to Friday, from
    8AM to 5:30PM.
  • Email:
  • Talk to the Ombudsman
Company information
  • Company registered with the Regional Council of Biology (CRBio) under No. 001800/01-D.
  • CEVS Sanitary License No. 354340218-864-004749-1-6.
  • National Register of Health Establishments – CNES: 0823104
  • Technical manager: Dr. Marcos Tadeu dos Santos – Molecular Biologist – CRBio No. 113094/01-D.
  • Home
  • mir-THYpe
  • Contact
  • Português
  • English
  • Home
  • mir-THYpe
  • Contact
  • Português
  • English

© 2025 Copyright Onkos